Cargando…
Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis()()
Neurofibromatosis type 1 still lacks established treatment options aimed at controlling the progression of neurofibromas as well as effective therapy for the neurogenic itch associated with the disease. We report the case of a 30-year-old Caucasian woman with type 1 neurofibromatosis coexisting with...
Autores principales: | Chello, Camilla, Sernicola, Alvise, Paolino, Giovanni, Grieco, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441471/ https://www.ncbi.nlm.nih.gov/pubmed/34275694 http://dx.doi.org/10.1016/j.abd.2020.10.006 |
Ejemplares similares
-
Impact of COVID-19 on patients with atopic dermatitis
por: Grieco, Teresa, et al.
Publicado: (2021) -
Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib
por: Grieco, Teresa, et al.
Publicado: (2023) -
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023) -
Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports
por: Zhu, Qing, et al.
Publicado: (2023) -
Dupilumab for atopic dermatitis
Publicado: (2019)